Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_52554 | 10 | 0.20 | Mlig455_008449, Mlig455_031351, Mlig455_031363, Mlig455_056520 | Neo: Int S/G2/M Age: Up-Down-Down |
CHRNA6 | Mlig455_008449 {REF} {Length: 3894} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=110.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=77.7]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=150, Expect=5e-40]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=152, Expect=1e-40]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=129, Expect=3e-32]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=142, Expect=3e-37]} {Smed: dd_Smed_v6_12182_0_1, dd_Smed_v6_12182_0_1, [Score=136, Expect=6e-35]} {RNA1509_7752} {RNA1310_10606.1} {RNA815_21386} Mlig455_031351 {REF} {Length: 1459} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=110.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=77.0]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=149, Expect=9e-39]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=150, Expect=2e-39]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=144, Expect=6e-37]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=130, Expect=3e-32]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=140, Expect=4e-36]} {Smed: dd_Smed_v6_12182_0_1, dd_Smed_v6_12182_0_1, [Score=135, Expect=5e-34]} {RNA1509_7752} {RNA1310_10606.1} {RNA815_31438} Mlig455_031363 {REF} {Length: 1072} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=113.8]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=82.4, Expect=6e-17]; ENSG00000149305, HTR3B, 5-hydroxytryptamine receptor 3B, [Score=81.3, Expect=1e-16]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=80.9, Expect=2e-16]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=79.0, Expect=7e-16]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=83.6, Expect=1e-17]; ENSMUSG00000008590, Htr3b, 5-hydroxytryptamine (serotonin) receptor 3B, [Score=81.6, Expect=6e-17]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=80.9, Expect=1e-16]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=80.5, Expect=2e-16]} {Dmel: FBgn0000038, nAChRbeta1, nicotinic Acetylcholine Receptor beta1, [Score=75.1, Expect=8e-15]} {Celegans: WBGene00000057, acr-18, AcetylCholine Receptor; Acetylcholine receptor, one of nine alpha a7-like nicotinic acetylcholine receptor subunits (58.6 kD) (Acr-18), [Score=85.9, Expect=1e-18]} {Smed: dd_Smed_v6_30253_0_1, dd_Smed_v6_30253_0_1, [Score=80.9, Expect=4e-17]} {RNA1509_53098} {RNA1310_10606.2} {RNA815_31438} Mlig455_056520 {REF} {Length: 2440} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=218.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=150.8]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=149, Expect=1e-37]; ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=146, Expect=6e-37]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=150, Expect=3e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=149, Expect=6e-38]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=129, Expect=5e-31]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=142, Expect=1e-35]} {Smed: dd_Smed_v6_12182_0_1, dd_Smed_v6_12182_0_1, [Score=137, Expect=9e-34]} {RNA1509_7752} {RNA1310_10606.1} {RNA815_31438} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | - | - | - | - | |
RegionR2 | - | - | - | - | |
RegionR3 | - | - | - | - | |
RegionR4 | - | - | - | - | |
RegionR5 | - | - | - | - | |
RegionR6 | - | - | - | - | |
RegionR7 | - | - | - | - | |
RegionR8 | - | - | - | - |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | - | - | - | - | |
RegenerationR2 | - | - | - | - | |
RegenerationR3 | - | - | - | - | |
RegenerationR4 | - | - | - | - | |
RegenerationR5 | - | - | - | - | |
RegenerationR6 | - | - | - | - | |
RegenerationBL | - | - | - | - | |
RegenerationTP | - | - | - | - |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_52554 | 10 | 0.2 | Mlig455_008449, Mlig455_031351, Mlig455_031363, Mlig455_056520 | Neo: Int S/G2/M Age: Up-Down-Down |
CHRNA6 | 2 | - | 1.000 | - | 1.000 | - | - | Mlig455_008449 {REF} {Length: 3894} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=110.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=77.7]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=150, Expect=5e-40]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=152, Expect=1e-40]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=129, Expect=3e-32]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=142, Expect=3e-37]} {Smed: dd_Smed_v6_12182_0_1, dd_Smed_v6_12182_0_1, [Score=136, Expect=6e-35]} {RNA1509_7752} {RNA1310_10606.1} {RNA815_21386} Mlig455_031351 {REF} {Length: 1459} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=110.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=77.0]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=149, Expect=9e-39]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=150, Expect=2e-39]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=144, Expect=6e-37]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=130, Expect=3e-32]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=140, Expect=4e-36]} {Smed: dd_Smed_v6_12182_0_1, dd_Smed_v6_12182_0_1, [Score=135, Expect=5e-34]} {RNA1509_7752} {RNA1310_10606.1} {RNA815_31438} Mlig455_031363 {REF} {Length: 1072} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=113.8]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=82.4, Expect=6e-17]; ENSG00000149305, HTR3B, 5-hydroxytryptamine receptor 3B, [Score=81.3, Expect=1e-16]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=80.9, Expect=2e-16]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=79.0, Expect=7e-16]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=83.6, Expect=1e-17]; ENSMUSG00000008590, Htr3b, 5-hydroxytryptamine (serotonin) receptor 3B, [Score=81.6, Expect=6e-17]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=80.9, Expect=1e-16]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=80.5, Expect=2e-16]} {Dmel: FBgn0000038, nAChRbeta1, nicotinic Acetylcholine Receptor beta1, [Score=75.1, Expect=8e-15]} {Celegans: WBGene00000057, acr-18, AcetylCholine Receptor; Acetylcholine receptor, one of nine alpha a7-like nicotinic acetylcholine receptor subunits (58.6 kD) (Acr-18), [Score=85.9, Expect=1e-18]} {Smed: dd_Smed_v6_30253_0_1, dd_Smed_v6_30253_0_1, [Score=80.9, Expect=4e-17]} {RNA1509_53098} {RNA1310_10606.2} {RNA815_31438} Mlig455_056520 {REF} {Length: 2440} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=218.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=150.8]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=149, Expect=1e-37]; ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=146, Expect=6e-37]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=150, Expect=3e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=149, Expect=6e-38]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=129, Expect=5e-31]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=142, Expect=1e-35]} {Smed: dd_Smed_v6_12182_0_1, dd_Smed_v6_12182_0_1, [Score=137, Expect=9e-34]} {RNA1509_7752} {RNA1310_10606.1} {RNA815_31438} |
2. | MligTC455_11110 | 100 | 2.08 | Mlig455_047439 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.339/0.01851 |
1.864 | - | 0.880 | - | 0.984 | - | - | Mlig455_047439 {REF} {Length: 1641} {RNA1310_49834.1} {RNA815_39415} | |
3. | MligTC455_11776 | 33 | 0.68 | Mlig455_048959 | Neo: - Age: - |
GABBR2 | 1.695 | - | 0.726 | - | 0.969 | - | - | Mlig455_048959 {REF} {Length: 2499} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=162.7]; Receptor family ligand binding region [PF01094.30, score=94.2]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=277, Expect=2e-80]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=273, Expect=5e-79]} {Dmel: FBgn0260446, GABA-B-R1, metabotropic GABA-B receptor subtype 1, [Score=252, Expect=4e-72]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=251, Expect=6e-72]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=134, Expect=4e-35]} {RNA1310_72017} {RNA815_50524} |
4. | MligTC455_38577 | 53 | 1.1 | Mlig455_039955, Mlig455_039969 | Neo: - Age: - |
1.671 | - | 0.717 | - | 0.954 | - | - | Mlig455_039955 {REF} {Length: 1584} {Pfam: Protein phosphatase inhibitor 2 (IPP-2) [PF04979.16, score=21.3]} {RNA1310_21615.2} {RNA815_35576} Mlig455_039969 {REF} {Length: 462} {NoTransDecoderORF} {RNA1310_21615.2} |
|
5. | MligTC455_40334 | 37 | 0.77 | Mlig455_060664 | Neo: - Age: - |
0.996 | - | - | - | 0.996 | - | - | Mlig455_060664 {REF} {Length: 529} {RNA1509_15938} {RNA1310_60401} {RNA815_36308} | |
6. | MligTC455_41910 | 46 | 0.96 | Mlig455_031932, Mlig455_032665, Mlig455_070395 | Neo: - Age: - |
0.994 | - | - | - | 0.994 | - | - | Mlig455_031932 {REF} {Length: 811} {Pfam: PAN-like domain [PF08277.14, score=21.2]; Carbohydrate binding domain (family 19) [PF03427.15, score=18.8]} {RNA1310_52317.2} {RNA815_34259} Mlig455_032665 {REF} {Length: 903} {Pfam: Carbohydrate binding domain (family 19) [PF03427.15, score=21.5]} {RNA1310_52317.1} {RNA815_34259} Mlig455_070395 {REF} {Length: 636} {Pfam: Carbohydrate binding domain (family 19) [PF03427.15, score=21.5]} {RNA1310_52317.1} {RNA815_34259} |
|
7. | MligTC455_33850 | 80 | 1.67 | Mlig455_015720 | Neo: - Age: - Region-enriched R2: 4.134/0.00338 |
0.991 | - | - | - | 0.991 | - | - | Mlig455_015720 {REF} {Length: 829} {RNA1509_37932} {RNA1310_98453} | |
8. | MligTC455_09501 | 17 | 0.36 | Mlig455_051721, Mlig455_051744 | Neo: Int S/G2/M Age: - |
0.99 | - | - | - | 0.990 | - | - | Mlig455_051721 {REF} {Length: 2673} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=142.6]} {Mouse: ENSMUSG00000028008, Asic5, acid-sensing (proton-gated) ion channel family member 5, [Score=60.8, Expect=2e-09]} {Smed: dd_Smed_v6_18385_0_1, dd_Smed_v6_18385_0_1, [Score=248, Expect=1e-73]} {RNA1509_19376} {RNA1310_47426} {RNA815_43225} Mlig455_051744 {REF} {Length: 1805} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=143.0]} {Mouse: ENSMUSG00000028008, Asic5, acid-sensing (proton-gated) ion channel family member 5, [Score=62.4, Expect=9e-10]} {Smed: dd_Smed_v6_18385_0_1, dd_Smed_v6_18385_0_1, [Score=246, Expect=7e-73]} {RNA1310_64849} {RNA815_43225} |
|
9. | MligTC455_18650 | 60 | 1.26 | Mlig455_061093 | Neo: - Age: - |
TNNT2 | 0.99 | - | - | - | 0.990 | - | - | Mlig455_061093 {REF} {Length: 1966} {Pfam: Troponin [PF00992.22, score=40.7]} {Human: ENSG00000118194, TNNT2, troponin T2, cardiac type, [RH, Score=60.5, Expect=1e-09]; ENSG00000130595, TNNT3, troponin T3, fast skeletal type, [RH, Score=60.1, Expect=8e-10]} {Mouse: ENSMUSG00000026414, Tnnt2, troponin T2, cardiac, [RH, Score=63.2, Expect=8e-11]; ENSMUSG00000061723, Tnnt3, troponin T3, skeletal, fast, [RH, Score=60.1, Expect=7e-10]} {Dmel: FBgn0004169, up, upheld, [Score=117, Expect=1e-29]} {Celegans: WBGene00006587, tnt-2, TropoNin T, [RH, Score=94.7, Expect=2e-21]} {Smed: dd_Smed_v6_375_0_1, dd_Smed_v6_375_0_1, [RH, Score=258, Expect=4e-84]} {RNA1509_55821} {RNA1310_24395} {RNA815_14986} |
10. | MligTC455_16334 | 23 | 0.47 | Mlig455_048897 | Neo: - Age: - |
GABBR2 | 0.989 | - | - | - | 0.989 | - | - | Mlig455_048897 {REF} {Length: 2632} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=156.6]; Receptor family ligand binding region [PF01094.30, score=109.3]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=307, Expect=2e-91]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=306, Expect=2e-91]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=267, Expect=5e-76]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=234, Expect=4e-66]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=129, Expect=2e-33]} {RNA1509_38426} {RNA1310_30172} {RNA815_43578} |
11. | MligTC455_16907 | 87 | 1.82 | Mlig455_008705 | Neo: - Age: Down-Up-Down |
SLC17A8 | 0.989 | - | - | - | 0.989 | - | - | Mlig455_008705 {REF} {Length: 1949} {Pfam: Major Facilitator Superfamily [PF07690.18, score=37.9]; SOCE-associated regulatory factor of calcium homoeostasis [PF06682.14, score=19.6]} {Human: ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [Score=213, Expect=1e-65]; ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [Score=212, Expect=1e-64]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [Score=208, Expect=6e-64]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [Score=215, Expect=1e-67]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [Score=211, Expect=1e-64]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [Score=207, Expect=4e-63]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=196, Expect=1e-58]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [Score=189, Expect=1e-56]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [Score=234, Expect=3e-73]} {RNA1509_38152} {RNA1310_19607.1} {RNA815_14894} |
12. | MligTC455_16606 | 108 | 2.26 | Mlig455_034973, Mlig455_053711, Mlig455_060000 | Neo: - Age: - Region-enriched R2: 5.697/0.00617 |
GLRA2 | 0.988 | - | - | - | 0.988 | - | - | Mlig455_034973 {REF} {Length: 1000} {RNA1310_100434} Mlig455_053711 {REF} {Length: 2327} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=52.0]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=60.8, Expect=3e-09]; ENSG00000109738, GLRB, glycine receptor beta, [Score=60.1, Expect=5e-09]} {Mouse: ENSMUSG00000023267, Gabrr2, gamma-aminobutyric acid (GABA) C receptor, subunit rho 2, [Score=61.6, Expect=1e-09]; ENSMUSG00000028020, Glrb, glycine receptor, beta subunit, [Score=61.2, Expect=2e-09]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=60.5, Expect=2e-09]} {Dmel: FBgn0010240, Lcch3, Ligand-gated chloride channel homolog 3, [Score=58.9, Expect=6e-09]} {Celegans: WBGene00001587, ggr-2, GABA/Glycine Receptor family (See gbr), [Score=60.8, Expect=1e-09]} {RNA1310_56609} {RNA815_37711} Mlig455_060000 {REF} {Length: 2781} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=52.0]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=62.0, Expect=1e-09]; ENSG00000109738, GLRB, glycine receptor beta, [Score=60.1, Expect=5e-09]} {Mouse: ENSMUSG00000023267, Gabrr2, gamma-aminobutyric acid (GABA) C receptor, subunit rho 2, [Score=62.0, Expect=7e-10]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=62.0, Expect=7e-10]; ENSMUSG00000028020, Glrb, glycine receptor, beta subunit, [Score=61.2, Expect=2e-09]} {Dmel: FBgn0010240, Lcch3, Ligand-gated chloride channel homolog 3, [Score=58.9, Expect=5e-09]} {Celegans: WBGene00001587, ggr-2, GABA/Glycine Receptor family (See gbr), [Score=60.8, Expect=1e-09]} {RNA1509_50322} {RNA1310_56609} {RNA815_37711} |
13. | MligTC455_17806 | 20 | 0.42 | Mlig455_044877 | Neo: - Age: - |
0.988 | - | - | - | 0.988 | - | - | Mlig455_044877 {REF} {Length: 1723} {Pfam: F5/8 type C domain [PF00754.27, score=29.9]} {Smed: dd_Smed_v6_83746_0_1, dd_Smed_v6_83746_0_1, [RH, Score=67.8, Expect=2e-14]} {RNA1310_72359} {RNA815_40265} | |
14. | MligTC455_35387 | 36 | 0.76 | Mlig455_022493 | Neo: - Age: - |
STOM | 0.988 | - | - | - | 0.988 | - | - | Mlig455_022493 {REF} {Length: 3725} {Pfam: SPFH domain / Band 7 family [PF01145.27, score=106.9]} {Human: ENSG00000148175, STOM, stomatin, [Score=318, Expect=2e-105]} {Mouse: ENSMUSG00000026880, Stom, stomatin, [Score=318, Expect=1e-105]} {Dmel: FBgn0260657, CG42540, [Score=333, Expect=4e-110]} {Celegans: WBGene00003166, mec-2, Mechanosensory protein 2, [Score=331, Expect=1e-110]} {Smed: dd_Smed_v6_6396_0_1, dd_Smed_v6_6396_0_1, [Score=392, Expect=4e-135]} {RNA1509_58730} {RNA1310_46627} {RNA815_48856} |
15. | MligTC455_40781 | 153 | 3.2 | Mlig455_024109, Mlig455_063982 | Neo: - Age: - |
0.988 | - | - | - | 0.988 | - | - | Mlig455_024109 {REF} {Length: 1081} {RNA1509_16458} {RNA1310_43664.1, RNA1509_16458} {RNA1509_16458, RNA815_23166} Mlig455_063982 {REF} {Length: 3562} {RNA1509_16458} {RNA1310_30070} {RNA815_23166} |
|
16. | MligTC455_43715 | 48 | 0.99 | Mlig455_034191 | Neo: - Age: Down-Up-Down Region-enriched R2: 7.969/0.00817 |
0.988 | - | - | - | 0.988 | - | - | Mlig455_034191 {REF} {Length: 895} {Pfam: WSC domain [PF01822.21, score=39.9]; PAN domain [PF14295.8, score=21.0]; PAN domain [PF00024.28, score=19.9]} {RNA1310_46313} {RNA815_23250} | |
17. | MligTC455_11109 | 30 | 0.62 | Mlig455_043718, Mlig455_043804 | Neo: - Age: Up-Down-Down |
0.987 | - | - | - | 0.987 | - | - | Mlig455_043718 {REF} {Length: 1591} {RNA1310_49834.1} {RNA815_39415} Mlig455_043804 {REF} {Length: 1594} {RNA1310_49834.2} {RNA815_39415} |
|
18. | MligTC455_40779 | 191 | 3.98 | Mlig455_000277, Mlig455_035731, Mlig455_058356 | Neo: - Age: - Region-enriched R4: 3.665/0.04268 |
0.987 | - | - | - | 0.987 | - | - | Mlig455_000277 {REF} {Length: 1048} {RNA1509_16458} {RNA1310_43664.1} {RNA815_23166} Mlig455_035731 {REF} {Length: 1048} {RNA1509_16458} {RNA1310_43664.1} {RNA815_23166} Mlig455_058356 {REF} {Length: 1050} {RNA1509_16458} {RNA1310_43664.1} {RNA815_23166} |
|
19. | MligTC455_20476 | 29 | 0.61 | Mlig455_009224 | Neo: - Age: - |
0.986 | - | - | - | 0.986 | - | - | Mlig455_009224 {REF} {Length: 1688} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=38.1]} {Dmel: FBgn0035385, FMRFaR, FMRFamide Receptor, [Score=49.7, Expect=2e-06]} {RNA1310_19222} {RNA815_35367} | |
20. | MligTC455_22254 | 7695 | 160.31 | Mlig455_000728, Mlig455_000775 | Neo: - Age: - Region-specific R2: 6.574 Region-enriched R2: 5.474/0.00000 |
0.986 | - | - | - | 0.986 | - | - | Mlig455_000728 {REF} {Length: 129} {NoTransDecoderORF} {RNA1509_2230} {RNA1310_11420} {RNA815_16323} Mlig455_000775 {REF} {Length: 126} {NoTransDecoderORF} {RNA1509_2230} {RNA1310_11420} {RNA815_16323} |
|
21. | MligTC455_37115 | 143 | 2.97 | Mlig455_020761 | Neo: - Age: - |
CA10 | 0.986 | - | - | - | 0.986 | - | - | Mlig455_020761 {REF} {Length: 2633} {Pfam: Eukaryotic-type carbonic anhydrase [PF00194.23, score=197.9]} {Human: ENSG00000154975, CA10, carbonic anhydrase 10, [RH, Score=193, Expect=1e-58]} {Mouse: ENSMUSG00000056158, Car10, carbonic anhydrase 10, [RH, Score=193, Expect=8e-59]} {Dmel: FBgn0029962, CG1402, [RH, Score=196, Expect=6e-60]} {Celegans: WBGene00000279, cah-1, Carbonic AnHydrase, [RH, Score=178, Expect=1e-53]} {Smed: dd_Smed_v6_15243_0_1, dd_Smed_v6_15243_0_1, [RH, Score=296, Expect=2e-99]} {RNA1509_19317} {RNA1310_15609, RNA1509_19317} {RNA1509_19317, RNA815_6866} |
22. | MligTC455_42520 | 221 | 4.6 | Mlig455_051277 | Neo: - Age: Down-Up-Up Region-specific R2: 7.331 Region-enriched R2: 7.171/0.00000 Regeneration-downregulated R2: -3.384 Regeneration-depleted R2: -3.384 |
0.986 | - | - | - | 0.986 | - | - | Mlig455_051277 {REF} {Length: 969} {RNA1310_42329} {RNA815_20649} | |
23. | MligTC455_44581 | 21 | 0.45 | Mlig455_051467, Mlig455_066697, Mlig455_066705 | Neo: - Age: - |
0.986 | - | - | - | 0.986 | - | - | Mlig455_051467 {REF} {Length: 1757} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=143.6]} {Smed: dd_Smed_v6_13556_0_1, dd_Smed_v6_13556_0_1, [Score=50.1, Expect=2e-06]} {RNA1310_22174} {RNA815_24783} Mlig455_066697 {REF} {Length: 2064} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=143.7]} {Smed: dd_Smed_v6_13556_0_1, dd_Smed_v6_13556_0_1, [Score=50.1, Expect=3e-06]} {RNA1310_22174} {RNA815_24783} Mlig455_066705 {REF} {Length: 2021} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=46.4]} {RNA1310_22174} {RNA815_24783} |
|
24. | MligTC455_08985 | 113 | 2.35 | Mlig455_040705, Mlig455_064574 | Neo: - Age: - Region-enriched R2: 4.395/0.00815 |
0.985 | - | - | - | 0.985 | - | - | Mlig455_040705 {REF} {Length: 2178} {NoTransDecoderORF} {RNA1509_57682} {RNA1310_91022} {RNA815_41716} Mlig455_064574 {REF} {Length: 4370} {Celegans: WBGene00006349, sur-2, Mediator of RNA polymerase II transcription subunit 23, [Score=48.5, Expect=1e-05]} {RNA1509_57682} {RNA1310_44678, RNA1509_57682} {RNA1509_57682, RNA815_41716} |
|
25. | MligTC455_11934 | 8 | 0.16 | Mlig455_008593, Mlig455_008607 | Neo: - Age: - |
GALR2 | 0.985 | - | - | - | 0.985 | - | - | Mlig455_008593 {REF} {Length: 1678} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=148.1]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=26.6]; Serpentine type 7TM GPCR chemoreceptor Sru [PF10322.11, score=19.9]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=145, Expect=3e-39]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=136, Expect=4e-36]} {Dmel: FBgn0036789, AstC-R2, Allatostatin C receptor 2, [Score=107, Expect=4e-25]} {Celegans: WBGene00013974, npr-9, Galanin-like G-protein coupled receptor npr-9, [Score=100, Expect=6e-23]} {Smed: dd_Smed_v6_15151_0_1, dd_Smed_v6_15151_0_1, [RH, Score=244, Expect=7e-77]} Mlig455_008607 {REF} {Length: 1678} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=148.1]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=26.6]; Serpentine type 7TM GPCR chemoreceptor Sru [PF10322.11, score=19.9]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=145, Expect=3e-39]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=136, Expect=4e-36]} {Dmel: FBgn0036789, AstC-R2, Allatostatin C receptor 2, [Score=107, Expect=4e-25]} {Celegans: WBGene00013974, npr-9, Galanin-like G-protein coupled receptor npr-9, [Score=100, Expect=6e-23]} {Smed: dd_Smed_v6_15151_0_1, dd_Smed_v6_15151_0_1, [RH, Score=244, Expect=7e-77]} |
26. | MligTC455_13435 | 10 | 0.21 | Mlig455_025954 | Neo: - Age: - |
0.985 | - | - | - | 0.985 | - | - | Mlig455_025954 {REF} {Length: 1663} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=35.5]} {RNA1310_51631} {RNA815_34338} | |
27. | MligTC455_17286 | 18 | 0.37 | Mlig455_062850, Mlig455_062932 | Neo: - Age: - |
NPFFR2, QRFPR | 0.985 | - | - | - | 0.985 | - | - | Mlig455_062850 {REF} {Length: 2774} {TRANSSPLICED} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=136.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=29.7]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=17.9]} {Human: ENSG00000186867, QRFPR, pyroglutamylated RFamide peptide receptor, [Score=132, Expect=1e-33]; ENSG00000056291, NPFFR2, neuropeptide FF receptor 2, [Score=130, Expect=4e-33]} {Mouse: ENSMUSG00000031212, Pgr15l, G protein-coupled receptor 15-like, [Score=137, Expect=9e-36]} {Dmel: FBgn0004841, TkR86C, Tachykinin-like receptor at 86C, [Score=138, Expect=9e-36]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=95.1, Expect=4e-21]} {Smed: dd_Smed_v6_17752_0_1, dd_Smed_v6_17752_0_1, [Score=105, Expect=1e-24]} {RNA1310_125205} Mlig455_062932 {REF} {Length: 1463} {TRANSSPLICED} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=135.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=29.3]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=19.2]} {Human: ENSG00000056291, NPFFR2, neuropeptide FF receptor 2, [Score=129, Expect=7e-33]; ENSG00000186867, QRFPR, pyroglutamylated RFamide peptide receptor, [Score=128, Expect=2e-32]} {Mouse: ENSMUSG00000031212, Pgr15l, G protein-coupled receptor 15-like, [Score=138, Expect=8e-36]} {Dmel: FBgn0004841, TkR86C, Tachykinin-like receptor at 86C, [Score=136, Expect=4e-35]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=95.1, Expect=4e-21]} {Smed: dd_Smed_v6_17752_0_1, dd_Smed_v6_17752_0_1, [Score=105, Expect=1e-24]} {RNA1310_125205} |
28. | MligTC455_25928 | 181 | 3.78 | Mlig455_006534, Mlig455_006538, Mlig455_006649, Mlig455_006700 | Neo: - Age: logFC(26M/2M)=-0.528 Region-specific R2: 7.256 Region-enriched R2: 5.788/0.02697 |
0.985 | - | - | - | 0.985 | - | - | Mlig455_006534 {REF} {Length: 689} {RNA1509_22927} {RNA1310_81957.1} {RNA815_41771.2} Mlig455_006538 {REF} {Length: 1691} {RNA1509_12380} {RNA1310_164.2} {RNA815_19957} Mlig455_006649 {REF} {Length: 829} {RNA1509_22927} {RNA1310_81957.1} {RNA815_41771.2} Mlig455_006700 {REF} {Length: 750} {RNA1509_22927} {RNA1310_81957.2} {RNA815_41771.2} |
|
29. | MligTC455_39495 | 30 | 0.62 | Mlig455_037087 | Neo: - Age: - |
0.985 | - | - | - | 0.985 | - | - | Mlig455_037087 {REF} {Length: 1984} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=38.4]} {Dmel: FBgn0035385, FMRFaR, FMRFamide Receptor, [Score=49.7, Expect=2e-06]} {RNA1310_19222} {RNA815_35367} | |
30. | MligTC455_41430 | 65 | 1.35 | Mlig455_070915 | Neo: - Age: - |
BHLHE22 | 0.985 | - | - | - | 0.985 | - | - | Mlig455_070915 {REF} {Length: 1052} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=58.4]} {Human: ENSG00000180828, BHLHE22, basic helix-loop-helix family member e22, [RH, Score=135, Expect=4e-37]} {Mouse: ENSMUSG00000025128, Bhlhe22, basic helix-loop-helix family, member e22, [RH, Score=133, Expect=8e-37]; ENSMUSG00000045493, Bhlhe23, basic helix-loop-helix family, member e23, [RH, Score=129, Expect=1e-36]} {Dmel: FBgn0032651, Oli, Olig family, [RH, Score=135, Expect=4e-39]} {Celegans: WBGene00001961, hlh-17, Helix Loop Helix, [RH, Score=103, Expect=2e-28]} {Smed: dd_Smed_v6_12722_0_1, dd_Smed_v6_12722_0_1, [RH, Score=129, Expect=2e-37]} {RNA1310_107478} |
31. | MligTC455_41854 | 80 | 1.67 | Mlig455_034307, Mlig455_067305, Mlig455_067321 | Neo: - Age: - |
0.985 | - | - | - | 0.985 | - | - | Mlig455_034307 {REF} {Length: 459} {RNA815_51696.1} Mlig455_067305 {REF} {Length: 466} {RNA815_51696.1} Mlig455_067321 {REF} {Length: 95} {TRANSSPLICED} {NoTransDecoderORF} {RNA815_51696.1} |
|
32. | MligTC455_42313 | 496 | 10.33 | Mlig455_047802 | Neo: - Age: Down-Up-Up Region-specific R2: 5.966 Region-enriched R2: 4.823/0.00000 Regeneration-downregulated R2: -2.674 Regeneration-depleted R2: -2.674 |
0.985 | - | - | - | 0.985 | - | - | Mlig455_047802 {REF} {Length: 1225} {Pfam: Hyaluronidase protein (HylP) [PF07212.13, score=21.5]} {RNA1509_51722} {RNA1310_51935, RNA1509_51722} {RNA1509_51722, RNA815_15783.2} | |
33. | MligTC455_42314 | 406 | 8.46 | Mlig455_052727 | Neo: - Age: - Region-enriched R2: 4.230/0.00183 |
0.985 | - | - | - | 0.985 | - | - | Mlig455_052727 {REF} {Length: 1339} {Pfam: Hyaluronidase protein (HylP) [PF07212.13, score=19.1]} {RNA1509_51722} {RNA1310_50605} {RNA815_15783.1} | |
34. | MligTC455_45943 | 66 | 1.38 | Mlig455_012164 | Neo: - Age: Up-Up-Down |
NPR2 | 0.985 | - | - | - | 0.985 | - | - | Mlig455_012164 {REF} {Length: 4580} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=225.3]; Receptor family ligand binding region [PF01094.30, score=169.5]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=126.7]; Protein kinase domain [PF00069.27, score=114.0]; Heme NO binding associated [PF07701.16, score=19.2]} {Human: ENSG00000159899, NPR2, natriuretic peptide receptor 2, [RH, Score=791, Expect=0.0]} {Mouse: ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [RH, Score=629, Expect=0.0]} {Dmel: FBgn0051183, CG31183, [RH, Score=826, Expect=0.0]} {Celegans: WBGene00020131, gcy-28, Receptor-type guanylate cyclase gcy-28, [RH, Score=600, Expect=0.0]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [RH, Score=955, Expect=0.0]} {RNA1509_42903} {RNA1310_5627} {RNA815_1811} |
35. | MligTC455_48064 | 23 | 0.48 | Mlig455_061550 | Neo: - Age: - |
0.985 | - | - | - | 0.985 | - | - | Mlig455_061550 {REF} {Length: 860} {RNA1310_88363} {RNA815_47885} | |
36. | MligTC455_48521 | 56 | 1.17 | Mlig455_004444 | Neo: - Age: - |
0.985 | - | - | - | 0.985 | - | - | Mlig455_004444 {REF} {Length: 3968} {Pfam: GDNF/GAS1 domain [PF02351.18, score=19.4]} {Smed: dd_Smed_v6_19517_0_1, dd_Smed_v6_19517_0_1, [RH, Score=111, Expect=3e-25]} {RNA1509_50708} {RNA1310_13399} {RNA815_27009} | |
37. | MligTC455_52656 | 121 | 2.51 | Mlig455_062381, Mlig455_062408 | Neo: - Age: Down-Up-Down |
0.985 | - | - | - | 0.985 | - | - | Mlig455_062381 {REF} {Length: 2245} {RNA1310_26272} {RNA815_22826} Mlig455_062408 {REF} {Length: 2277} {RNA1310_26272} {RNA815_37592} |
|
38. | MligTC455_53333 | 44 | 0.91 | Mlig455_019019, Mlig455_055684 | Neo: - Age: Up-Down-Up Region-enriched R4: 4.725/0.03950 |
CHRNA7 | 0.985 | - | - | - | 0.985 | - | - | Mlig455_019019 {REF} {Length: 2615} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=154.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=93.9]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=210, Expect=2e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=208, Expect=5e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=207, Expect=8e-59]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=206, Expect=3e-58]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=209, Expect=1e-59]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=205, Expect=3e-58]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=221, Expect=3e-63]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=190, Expect=7e-53]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [Score=426, Expect=5e-142]} {RNA1509_56207} {RNA1310_26355} {RNA815_26644} Mlig455_055684 {REF} {Length: 2604} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=154.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=94.7]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=211, Expect=9e-60]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=209, Expect=3e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=208, Expect=5e-59]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=207, Expect=7e-59]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=209, Expect=9e-60]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=204, Expect=1e-57]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=222, Expect=1e-63]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=190, Expect=6e-53]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [Score=427, Expect=3e-142]} {RNA1509_56207} {RNA1310_26355} {RNA815_26644} |
39. | MligTC455_53788 | 175 | 3.65 | Mlig455_046938 | Neo: - Age: Up-Down-Down |
PATJ | 0.985 | - | - | - | 0.985 | - | - | Mlig455_046938 {REF} {Length: 2899} {Pfam: PDZ domain [PF00595.26, score=86.8]; PDZ domain [PF17820.3, score=53.6]; PDZ domain [PF13180.8, score=51.0]; Family of unknown function (DUF6288) [PF19805.1, score=24.2]} {Human: ENSG00000132849, PATJ, PATJ, crumbs cell polarity complex component, [Score=80.5, Expect=1e-16]} {Mouse: ENSMUSG00000028402, Mpdz, multiple PDZ domain protein, [Score=74.7, Expect=7e-15]} {Dmel: FBgn0087007, bbg, big bang, [Score=58.2, Expect=2e-09]} {Celegans: WBGene00003404, mpz-1, Multiple PDZ domain protein, [Score=56.6, Expect=5e-09]} {Smed: dd_Smed_v6_854_0_3, dd_Smed_v6_854_0_3, [Score=65.1, Expect=7e-12]} {RNA1509_37898} {RNA1310_15726, RNA1509_37898} {RNA1509_37898, RNA815_2967} |
40. | MligTC455_15329 | 22 | 0.47 | Mlig455_060498 | Neo: - Age: - |
0.984 | - | - | - | 0.984 | - | - | Mlig455_060498 {REF} {Length: 1186} {Pfam: PAN domain [PF00024.28, score=18.9]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=63.9, Expect=4e-12]} {RNA1310_37660} {RNA815_17816.1} | |
41. | MligTC455_18505 | 15 | 0.31 | Mlig455_017536 | Neo: - Age: - |
0.984 | - | - | - | 0.984 | - | - | Mlig455_017536 {REF} {Length: 2174} {RNA1310_61282} {RNA815_41334} | |
42. | MligTC455_33264 | 88 | 1.84 | Mlig455_055165 | Neo: - |
SLC17A8 | 0.984 | - | - | - | 0.984 | - | - | Mlig455_055165 {REF} {Length: 2530} {Pfam: Major Facilitator Superfamily [PF07690.18, score=65.4]} {Human: ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [Score=129, Expect=5e-31]; ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [Score=128, Expect=6e-31]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [Score=124, Expect=1e-29]} {Mouse: ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [Score=130, Expect=1e-31]; ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [Score=130, Expect=2e-31]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [Score=130, Expect=1e-31]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=112, Expect=6e-26]} {Celegans: WBGene00017681, slc-17.5, SLC (SoLute Carrier) homolog, [Score=66.6, Expect=2e-11]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [Score=125, Expect=3e-30]} {RNA1509_54006} {RNA1310_10685, RNA1509_54006} {RNA1509_54006, RNA815_25744} |
43. | MligTC455_36950 | 42 | 0.88 | Mlig455_022867 | Neo: - Age: - |
KIAA1217 | 0.984 | - | - | - | 0.984 | - | - | Mlig455_022867 {REF} {Length: 3173} {Human: ENSG00000120549, KIAA1217, KIAA1217, [RH, Score=72.4, Expect=3e-12]} {Mouse: ENSMUSG00000036617, Etl4, enhancer trap locus 4, [RH, Score=65.9, Expect=2e-10]} {Dmel: FBgn0023531, CG32809, [Score=70.9, Expect=4e-12]} {Celegans: WBGene00022180, Y71H2AM.15, [RH, Score=62.0, Expect=1e-09]} {RNA1310_85458} {RNA815_59686} |
44. | MligTC455_48063 | 63 | 1.31 | Mlig455_046268 | Neo: - Age: - Region-enriched R2: 5.256/0.00170 |
0.984 | - | - | - | 0.984 | - | - | Mlig455_046268 {REF} {Length: 749} {RNA1310_88363} {RNA815_47885} | |
45. | MligTC455_03081 | 39 | 0.81 | Mlig455_026877, Mlig455_030777, Mlig455_030817 | Neo: - Age: - |
FO681492.1 | 0.983 | - | - | - | 0.983 | - | - | Mlig455_026877 {REF} {Length: 2007} {Pfam: C2 domain [PF00168.32, score=67.2]} {Human: ENSG00000277758, FO681492.1, synaptotagmin-15, [Score=92.8, Expect=1e-19]; ENSG00000204176, SYT15, synaptotagmin 15, [Score=92.4, Expect=1e-19]} {Mouse: ENSMUSG00000041479, Syt15, synaptotagmin XV, [Score=86.3, Expect=1e-17]} {Dmel: FBgn0004242, Syt1, Synaptotagmin 1, [Score=67.4, Expect=1e-11]} {Smed: dd_Smed_v6_16731_0_1, dd_Smed_v6_16731_0_1, [RH, Score=129, Expect=1e-32]} {RNA1509_21228} {RNA1310_103420} {RNA815_7856.1} Mlig455_030777 {REF} {Length: 2035} {Pfam: C2 domain [PF00168.32, score=67.2]} {Human: ENSG00000277758, FO681492.1, synaptotagmin-15, [Score=94.0, Expect=6e-20]; ENSG00000204176, SYT15, synaptotagmin 15, [Score=93.6, Expect=5e-20]} {Mouse: ENSMUSG00000041479, Syt15, synaptotagmin XV, [Score=86.3, Expect=1e-17]} {Dmel: FBgn0004242, Syt1, Synaptotagmin 1, [Score=68.9, Expect=4e-12]} {Smed: dd_Smed_v6_16731_0_1, dd_Smed_v6_16731_0_1, [RH, Score=130, Expect=8e-33]} {RNA1509_21228} {RNA1310_103420} {RNA815_7856.1} Mlig455_030817 {REF} {Length: 2853} {Pfam: C2 domain [PF00168.32, score=66.7]} {Human: ENSG00000277758, FO681492.1, synaptotagmin-15, [Score=92.8, Expect=1e-19]; ENSG00000204176, SYT15, synaptotagmin 15, [Score=92.8, Expect=1e-19]} {Mouse: ENSMUSG00000041479, Syt15, synaptotagmin XV, [Score=86.7, Expect=7e-18]} {Dmel: FBgn0004242, Syt1, Synaptotagmin 1, [Score=65.9, Expect=4e-11]} {Smed: dd_Smed_v6_16731_0_1, dd_Smed_v6_16731_0_1, [RH, Score=130, Expect=6e-33]} {RNA1509_47157} {RNA1310_77313} {RNA815_44967} |
46. | MligTC455_12971 | 15 | 0.3 | Mlig455_023929 | Neo: - Age: - |
0.983 | - | - | - | 0.983 | - | - | Mlig455_023929 {REF} {Length: 305} {NoTransDecoderORF} | |
47. | MligTC455_19235 | 18 | 0.38 | Mlig455_013768 | Neo: - Age: - |
0.983 | - | - | - | 0.983 | - | - | Mlig455_013768 {REF} {Length: 2312} {Pfam: Glycine rich protein [PF12810.9, score=36.9]; PAN domain [PF00024.28, score=24.7]} {RNA1310_126710} {RNA815_35307} | |
48. | MligTC455_21682 | 14 | 0.3 | Mlig455_004890 | Neo: - Age: - |
0.983 | - | - | - | 0.983 | - | - | Mlig455_004890 {REF} {Length: 1011} {Pfam: Lectin C-type domain [PF00059.23, score=29.2]} {Mouse: ENSMUSG00000079168, Cd209g, CD209g antigen, [Score=50.4, Expect=3e-07]; ENSMUSG00000065987, Cd209b, CD209b antigen, [Score=48.1, Expect=4e-06]} {Smed: dd_Smed_v6_85740_0_1, dd_Smed_v6_85740_0_1, [Score=51.6, Expect=2e-08]} {RNA1310_61965} {RNA815_21285} | |
49. | MligTC455_36567 | 18 | 0.37 | Mlig455_065030 | Neo: - Age: - |
0.983 | - | - | - | 0.983 | - | - | Mlig455_065030 {REF} {Length: 672} | |
50. | MligTC455_37188 | 31 | 0.65 | Mlig455_000345 | Neo: - Age: - |
TRAF5 | 0.983 | - | - | - | 0.983 | - | - | Mlig455_000345 {REF} {Length: 892} {Human: ENSG00000082512, TRAF5, TNF receptor associated factor 5, [Score=67.8, Expect=2e-12]; ENSG00000076604, TRAF4, TNF receptor associated factor 4, [Score=65.5, Expect=8e-12]} {Mouse: ENSMUSG00000111385, Traf5, TNF receptor-associated factor 5, [Score=75.1, Expect=8e-16]; ENSMUSG00000026637, Traf5, TNF receptor-associated factor 5, [Score=75.1, Expect=8e-16]} {Dmel: FBgn0026319, Traf4, TNF-receptor-associated factor 4, [Score=65.1, Expect=6e-12]} {Celegans: WBGene00006612, trf-1, TNF Receptor Associated Factor (TRAF) homolog; TRF-1, [Score=92.0, Expect=3e-21]} {Smed: dd_Smed_v6_13517_0_1, dd_Smed_v6_13517_0_1, [Score=108, Expect=5e-27]} |
51. | MligTC455_37748 | 123 | 2.56 | Mlig455_012702, Mlig455_033010 | Neo: - Age: - |
0.983 | - | - | - | 0.983 | - | - | Mlig455_012702 {REF} {Length: 2807} {Smed: dd_Smed_v6_32414_0_1, dd_Smed_v6_32414_0_1, [Score=87.0, Expect=4e-18]} {RNA1509_52343} {RNA1310_5679} {RNA815_10252} Mlig455_033010 {REF} {Length: 3464} {Smed: dd_Smed_v6_13730_0_1, dd_Smed_v6_13730_0_1, [Score=174, Expect=4e-45]} {RNA1509_52343} {RNA1310_5679} {RNA815_10252} |
|
52. | MligTC455_39253 | 9 | 0.18 | Mlig455_043542 | Neo: - Age: - |
0.983 | - | - | - | 0.983 | - | - | Mlig455_043542 {REF} {Length: 1849} {NoTransDecoderORF} {RNA1509_58635} {RNA1310_49396} {RNA815_42296} | |
53. | MligTC455_43716 | 30 | 0.62 | Mlig455_034199 | Neo: - Age: - |
0.983 | - | - | - | 0.983 | - | - | Mlig455_034199 {REF} {Length: 953} {Pfam: WSC domain [PF01822.21, score=39.9]; PAN domain [PF14295.8, score=21.0]; PAN domain [PF00024.28, score=19.9]} {RNA1310_46313} {RNA815_23250} | |
54. | MligTC455_25072 | 4443 | 92.56 | Mlig455_015899 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.175 Region-enriched R2: 4.389/0.00000 |
PI16 | 0.982 | - | - | - | 0.982 | - | - | Mlig455_015899 {REF} {Length: 2017} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=71.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=112, Expect=1e-26]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [RH, Score=115, Expect=5e-28]} {Dmel: FBgn0038126, CG8483, [Score=95.5, Expect=2e-21]} {Celegans: WBGene00011462, vap-2, Venom-Allergen-like Protein, [RH, Score=85.5, Expect=5e-18]} {Smed: dd_Smed_v6_2512_0_1, dd_Smed_v6_2512_0_1, [Score=140, Expect=2e-39]} {RNA1509_5027} {RNA1310_1356.1} {RNA815_4508} |
55. | MligTC455_25073 | 1271 | 26.47 | Mlig455_015905 | Neo: - Age: logFC(26M/2M)=-0.947 Region-specific R2: 3.291 Region-enriched R2: 2.110/0.00052 |
PI16 | 0.982 | - | - | - | 0.982 | - | - | Mlig455_015905 {REF} {Length: 2189} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=71.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=111, Expect=1e-26]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [RH, Score=115, Expect=7e-28]} {Dmel: FBgn0038126, CG8483, [Score=95.1, Expect=2e-21]} {Celegans: WBGene00011462, vap-2, Venom-Allergen-like Protein, [RH, Score=85.5, Expect=3e-18]} {Smed: dd_Smed_v6_2512_0_1, dd_Smed_v6_2512_0_1, [Score=140, Expect=2e-39]} {RNA1509_36129, RNA1509_46021, RNA1509_5027} {RNA1310_1356.1, RNA1509_36129, RNA1509_46021} {RNA1509_36129, RNA1509_46021, RNA815_4508} |
56. | MligTC455_27216 | 56 | 1.18 | Mlig455_022418 | Neo: - |
TRPM3 | 0.982 | - | - | - | 0.982 | - | - | Mlig455_022418 {REF} {Length: 4794} {Pfam: SLOG in TRPM [PF18139.3, score=136.8]; Ion transport protein [PF00520.33, score=41.0]; SLOG in TRPM, prokaryote [PF18171.3, score=34.2]} {Human: ENSG00000083067, TRPM3, transient receptor potential cation channel subfamily M member 3, [Score=317, Expect=2e-88]; ENSG00000119121, TRPM6, transient receptor potential cation channel subfamily M member 6, [Score=316, Expect=4e-88]} {Mouse: ENSMUSG00000052387, Trpm3, transient receptor potential cation channel, subfamily M, member 3, [Score=319, Expect=4e-90]} {Dmel: FBgn0265194, Trpm, Transient receptor potential cation channel, subfamily M, [Score=309, Expect=7e-88]} {Celegans: WBGene00001796, gtl-2, Gon-Two Like (TRP subfamily), [Score=255, Expect=4e-69]} {Smed: dd_Smed_v6_9288_0_1, dd_Smed_v6_9288_0_1, [Score=418, Expect=3e-126]} {RNA1509_17593} {RNA1310_1651, RNA1509_17593} {RNA1509_17593, RNA815_2281} |
57. | MligTC455_53827 | 41 | 0.85 | Mlig455_057728 | Neo: - Age: - Region-enriched R2: 6.363/0.00033 |
0.982 | - | - | - | 0.982 | - | - | Mlig455_057728 {REF} {Length: 1074} {RNA1310_41119} {RNA815_15825} | |
58. | MligTC455_13576 | 29 | 0.61 | Mlig455_054113 | Neo: - Age: - Regeneration-upregulated R2: 5.145 Regeneration-enriched R2: 5.145 |
0.981 | - | - | - | 0.981 | - | - | Mlig455_054113 {REF} {Length: 5953} {RNA1509_49393} {RNA1310_44225} {RNA815_34559} | |
59. | MligTC455_19552 | 288 | 6 | Mlig455_055936, Mlig455_068188 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.424 Region-specific R2: 6.302 Region-enriched R2: 4.919/0.00633 Regeneration-depleted R4: -5.607 |
0.981 | - | - | - | 0.981 | - | - | Mlig455_055936 {REF} {Length: 665} {RNA1310_71052} {RNA815_36745} Mlig455_068188 {REF} {Length: 714} {RNA1310_71052} {RNA815_36745} |
|
60. | MligTC455_39838 | 117 | 2.44 | Mlig455_061337, Mlig455_062688 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.720/0.01251 |
PROP1 | 0.981 | - | - | - | 0.981 | - | - | Mlig455_061337 {REF} {Length: 2182} {Pfam: Homeodomain [PF00046.31, score=77.0]} {Human: ENSG00000175325, PROP1, PROP paired-like homeobox 1, [RH, Score=97.8, Expect=9e-23]; ENSG00000274382, PROP1, PROP paired-like homeobox 1, [RH, Score=97.8, Expect=9e-23]} {Mouse: ENSMUSG00000028736, Pax7, paired box 7, [Score=103, Expect=4e-23]; ENSMUSG00000036602, Alx1, ALX homeobox 1, [Score=102, Expect=4e-24]; ENSMUSG00000024518, Rax, retina and anterior neural fold homeobox, [Score=101, Expect=3e-23]; ENSMUSG00000035277, Arx, aristaless related homeobox, [Score=100, Expect=4e-22]; ENSMUSG00000040310, Alx4, aristaless-like homeobox 4, [Score=100, Expect=9e-23]; ENSMUSG00000014603, Alx3, aristaless-like homeobox 3, [Score=99.0, Expect=2e-22]} {Dmel: FBgn0052532, CG32532, [RH, Score=188, Expect=3e-55]} {Celegans: WBGene00006778, unc-42, [RH, Score=152, Expect=1e-42]} {Smed: dd_Smed_v6_21801_0_1, dd_Smed_v6_21801_0_1, [RH, Score=211, Expect=9e-63]} {RNA1310_35015.1} {RNA815_23154} Mlig455_062688 {REF} {Length: 2531} {Pfam: Homeodomain [PF00046.31, score=77.5]} {Human: ENSG00000274382, PROP1, PROP paired-like homeobox 1, [RH, Score=99.0, Expect=1e-23]; ENSG00000175325, PROP1, PROP paired-like homeobox 1, [RH, Score=99.0, Expect=1e-23]} {Mouse: ENSMUSG00000036602, Alx1, ALX homeobox 1, [Score=103, Expect=5e-25]; ENSMUSG00000028736, Pax7, paired box 7, [Score=103, Expect=5e-24]; ENSMUSG00000024518, Rax, retina and anterior neural fold homeobox, [Score=102, Expect=4e-24]; ENSMUSG00000040310, Alx4, aristaless-like homeobox 4, [Score=102, Expect=8e-24]; ENSMUSG00000035277, Arx, aristaless related homeobox, [Score=101, Expect=4e-23]; ENSMUSG00000014603, Alx3, aristaless-like homeobox 3, [Score=100, Expect=2e-23]; ENSMUSG00000004872, Pax3, paired box 3, [Score=99.4, Expect=2e-22]; ENSMUSG00000012520, Phox2b, paired-like homeobox 2b, [Score=98.2, Expect=7e-23]} {Dmel: FBgn0052532, CG32532, [RH, Score=189, Expect=2e-56]} {Celegans: WBGene00006778, unc-42, [RH, Score=155, Expect=1e-44]} {Smed: dd_Smed_v6_21801_0_1, dd_Smed_v6_21801_0_1, [RH, Score=212, Expect=2e-64]} {RNA1310_35015.1} {RNA815_23154} |
61. | MligTC455_42484 | 246 | 5.12 | Mlig455_046416 | Neo: - Age: Down-Up-Down Region-specific R2: 4.313 Region-enriched R2: 2.983/0.00930 |
0.981 | - | - | - | 0.981 | - | - | Mlig455_046416 {REF} {Length: 1006} {RNA1310_40237.1} {RNA815_18246} | |
62. | MligTC455_10439 | 11 | 0.23 | Mlig455_000558, Mlig455_030354 | Neo: - Age: - |
FGG | 0.98 | - | - | - | 0.980 | - | - | Mlig455_000558 {REF} {Length: 2277} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=120.6]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=55.7]} {Human: ENSG00000171557, FGG, fibrinogen gamma chain, [Score=107, Expect=5e-24]} {Mouse: ENSMUSG00000033860, Fgg, fibrinogen gamma chain, [Score=100, Expect=3e-22]} {Dmel: FBgn0051832, CG31832, [Score=88.2, Expect=2e-19]} {Celegans: WBGene00012782, Y43C5A.2, [RH, Score=54.3, Expect=2e-07]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=72.8, Expect=3e-13]} {RNA1310_33683.1} {RNA815_41841} Mlig455_030354 {REF} {Length: 2960} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=118.9]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=56.7]} {Human: ENSG00000171557, FGG, fibrinogen gamma chain, [Score=104, Expect=3e-23]} {Mouse: ENSMUSG00000033860, Fgg, fibrinogen gamma chain, [Score=98.6, Expect=2e-21]; ENSMUSG00000039899, Fgl2, fibrinogen-like protein 2, [Score=95.5, Expect=2e-20]; ENSMUSG00000026835, Fcnb, ficolin B, [Score=94.4, Expect=1e-20]} {Dmel: FBgn0051832, CG31832, [Score=89.4, Expect=8e-20]} {Celegans: WBGene00012782, Y43C5A.2, [Score=48.9, Expect=9e-06]} {Smed: dd_Smed_v6_21509_0_1, dd_Smed_v6_21509_0_1, [Score=80.1, Expect=6e-16]} {RNA1509_41312} {RNA1310_33683.1} {RNA815_41841} |
63. | MligTC455_13249 | 72 | 1.5 | Mlig455_028005, Mlig455_028032 | Neo: - Age: Up-Down-Up |
IGSF9B | 0.98 | - | - | - | 0.980 | - | - | Mlig455_028005 {REF} {Length: 4846} {Pfam: Immunoglobulin domain [PF13927.8, score=163.0]; Immunoglobulin I-set domain [PF07679.18, score=129.4]; Immunoglobulin domain [PF13895.8, score=110.9]; Immunoglobulin domain [PF00047.27, score=102.5]; Immunoglobulin V-set domain [PF07686.19, score=68.9]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=31.1]; Fibronectin type III domain [PF00041.23, score=27.5]; Izumo-like Immunoglobulin domain [PF16706.7, score=22.6]; Immunoglobulin C1-set domain [PF07654.17, score=22.1]; Immunoglobulin domain [PF18452.3, score=20.9]; Tissue factor [PF01108.19, score=19.1]} {Human: ENSG00000080854, IGSF9B, immunoglobulin superfamily member 9B, [RH, Score=232, Expect=2e-62]; ENSG00000085552, IGSF9, immunoglobulin superfamily member 9, [RH, Score=228, Expect=3e-61]} {Mouse: ENSMUSG00000034275, Igsf9b, immunoglobulin superfamily, member 9B, [RH, Score=232, Expect=1e-64]; ENSMUSG00000037995, Igsf9, immunoglobulin superfamily, member 9, [RH, Score=222, Expect=2e-59]} {Dmel: FBgn0010473, tutl, turtle, [RH, Score=250, Expect=5e-70]} {Celegans: WBGene00020130, igcm-2, ImmunoGlobulin-like Cell adhesion Molecule family, [RH, Score=147, Expect=2e-36]} {Smed: dd_Smed_v6_17743_0_1, dd_Smed_v6_17743_0_1, [RH, Score=239, Expect=1e-65]} {RNA1509_10844} {RNA1310_32662} {RNA815_30370} Mlig455_028032 {REF} {Length: 2715} {Pfam: Immunoglobulin domain [PF13927.8, score=136.6]; Immunoglobulin I-set domain [PF07679.18, score=112.1]; Immunoglobulin domain [PF13895.8, score=96.2]; Immunoglobulin domain [PF00047.27, score=94.6]; Immunoglobulin V-set domain [PF07686.19, score=38.5]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=30.1]; Fibronectin type III domain [PF00041.23, score=28.0]; Tissue factor [PF01108.19, score=23.2]; Immunoglobulin C1-set domain [PF07654.17, score=21.7]} {Human: ENSG00000080854, IGSF9B, immunoglobulin superfamily member 9B, [Score=183, Expect=4e-47]; ENSG00000085552, IGSF9, immunoglobulin superfamily member 9, [Score=181, Expect=3e-46]} {Mouse: ENSMUSG00000034275, Igsf9b, immunoglobulin superfamily, member 9B, [Score=184, Expect=2e-47]; ENSMUSG00000037995, Igsf9, immunoglobulin superfamily, member 9, [Score=175, Expect=8e-45]} {Dmel: FBgn0010473, tutl, turtle, [Score=207, Expect=6e-56]} {Celegans: WBGene00020130, igcm-2, ImmunoGlobulin-like Cell adhesion Molecule family, [RH, Score=145, Expect=5e-36]} {Smed: dd_Smed_v6_17743_0_1, dd_Smed_v6_17743_0_1, [Score=203, Expect=2e-54]} {RNA1509_36563} {RNA1310_113619} |
64. | MligTC455_19412 | 42 | 0.88 | Mlig455_047997 | Neo: - Age: - |
0.98 | - | - | - | 0.980 | - | - | Mlig455_047997 {REF} {Length: 701} {RNA1310_53549} {RNA815_27051} | |
65. | MligTC455_35735 | 24 | 0.5 | Mlig455_016835, Mlig455_016847 | Neo: - Age: - |
0.98 | - | - | - | 0.980 | - | - | Mlig455_016835 {REF} {Length: 1740} {RNA1310_88085} Mlig455_016847 {REF} {Length: 1571} {RNA1310_88085} |
|
66. | MligTC455_51009 | 16 | 0.33 | Mlig455_057754 | Neo: - Age: - |
0.98 | - | - | - | 0.980 | - | - | Mlig455_057754 {REF} {Length: 198} {NoTransDecoderORF} | |
67. | MligTC455_53869 | 27 | 0.57 | Mlig455_060247 | Neo: - Age: - |
CHDH | 0.98 | - | - | - | 0.980 | - | - | Mlig455_060247 {REF} {Length: 2837} {Pfam: GMC oxidoreductase [PF00732.21, score=82.3]; GMC oxidoreductase [PF05199.15, score=61.5]; FAD dependent oxidoreductase [PF01266.26, score=20.3]; Lycopene cyclase protein [PF05834.14, score=18.0]} {Human: ENSG00000016391, CHDH, choline dehydrogenase, [Score=101, Expect=6e-22]} {Mouse: ENSMUSG00000015970, Chdh, choline dehydrogenase, [Score=103, Expect=9e-23]} {Dmel: FBgn0037896, ninaG, [Score=116, Expect=3e-27]} {Celegans: WBGene00007917, C34C6.4, [Score=65.9, Expect=4e-11]} {Smed: dd_Smed_v6_13047_0_2, dd_Smed_v6_13047_0_2, [RH, Score=166, Expect=2e-44]} {RNA1310_47881.1} |
68. | MligTC455_10228 | 50 | 1.05 | Mlig455_023553 | Neo: - Age: - |
0.979 | - | - | - | 0.979 | - | - | Mlig455_023553 {REF} {Length: 1195} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.0]} {RNA1310_22533.1} {RNA815_23050} | |
69. | MligTC455_24613 | 18 | 0.37 | Mlig455_005738 | Neo: - Age: - |
0.979 | - | - | - | 0.979 | - | - | Mlig455_005738 {REF} {Length: 1416} {Pfam: Lectin C-type domain [PF00059.23, score=20.0]} {RNA1310_35102} {RNA815_16139} | |
70. | MligTC455_26519 | 183 | 3.82 | Mlig455_030983, Mlig455_069440 | Neo: - Age: - |
0.979 | - | - | - | 0.979 | - | - | Mlig455_030983 {REF} {Length: 688} {RNA1509_12904} {RNA1310_62229} {RNA815_56172} Mlig455_069440 {REF} {Length: 1096} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=54.9]} {RNA1509_35362} {RNA1310_21423.2} {RNA815_13686} |
|
71. | MligTC455_30159 | 107 | 2.22 | Mlig455_008465, Mlig455_009916 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.961/0.00498 |
TCF7L1 | 0.979 | - | - | - | 0.979 | - | - | Mlig455_008465 {REF} {Length: 2454} {Pfam: HMG (high mobility group) box [PF00505.21, score=81.3]; HMG-box domain [PF09011.12, score=34.6]} {Human: ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=161, Expect=7e-43]; ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=3e-43]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=156, Expect=8e-42]} {Mouse: ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=161, Expect=4e-43]; ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=4e-44]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=155, Expect=6e-43]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=157, Expect=4e-41]} {Celegans: WBGene00004077, pop-1, [Score=108, Expect=2e-25]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=166, Expect=2e-48]} {RNA1310_11181} {RNA815_36690} Mlig455_009916 {REF} {Length: 2137} {Pfam: HMG (high mobility group) box [PF00505.21, score=81.4]; HMG-box domain [PF09011.12, score=34.7]} {Human: ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=161, Expect=4e-43]; ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=2e-43]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=157, Expect=5e-42]} {Mouse: ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=162, Expect=2e-43]; ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=3e-44]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=155, Expect=4e-43]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=157, Expect=3e-41]} {Celegans: WBGene00004077, pop-1, [Score=108, Expect=2e-25]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=166, Expect=1e-48]} {RNA1310_11181} {RNA815_36690} |
72. | MligTC455_30843 | 9 | 0.19 | Mlig455_031819 | Neo: - Age: - |
ANKRD52 | 0.979 | - | - | - | 0.979 | - | - | Mlig455_031819 {REF} {Length: 2449} {Pfam: Protein kinase domain [PF00069.27, score=78.3]; Ankyrin repeats (3 copies) [PF12796.9, score=72.1]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=56.1]; Ankyrin repeats (many copies) [PF13637.8, score=55.1]; Ankyrin repeats (many copies) [PF13857.8, score=51.8]; Ankyrin repeat [PF00023.32, score=40.8]; Ankyrin repeat [PF13606.8, score=39.7]} {Human: ENSG00000139645, ANKRD52, ankyrin repeat domain 52, [Score=71.2, Expect=3e-12]; ENSG00000065413, ANKRD44, ankyrin repeat domain 44, [Score=70.9, Expect=3e-12]} {Mouse: ENSMUSG00000014498, Ankrd52, ankyrin repeat domain 52, [Score=74.7, Expect=2e-13]; ENSMUSG00000052331, Ankrd44, ankyrin repeat domain 44, [Score=71.2, Expect=2e-12]} {Dmel: FBgn0024329, Mekk1, [Score=71.6, Expect=1e-12]} {Celegans: WBGene00006616, trp-4, TRP (Transient receptor potential) channel family, [Score=62.4, Expect=7e-10]} {Smed: dd_Smed_v6_17293_0_1, dd_Smed_v6_17293_0_1, [Score=60.1, Expect=1e-09]} {RNA1509_26758} {RNA1310_10050} {RNA815_10088.1} |
73. | MligTC455_48935 | 27 | 0.57 | Mlig455_041669 | Neo: - Age: - |
0.979 | - | - | - | 0.979 | - | - | Mlig455_041669 {REF} {Length: 1052} {Smed: dd_Smed_v6_3795_0_1, dd_Smed_v6_3795_0_1, [Score=56.2, Expect=8e-10]} {RNA1310_58309} {RNA815_39074} | |
74. | MligTC455_49304 | 46 | 0.95 | Mlig455_044321 | Neo: - Age: - |
0.979 | - | - | - | 0.979 | - | - | Mlig455_044321 {REF} {Length: 701} {RNA1509_20965} {RNA1310_92283} | |
75. | MligTC455_53546 | 130 | 2.72 | Mlig455_013326, Mlig455_013334 | Neo: - Age: - Region-enriched R2: 6.753/0.01892 |
MMP9 | 0.979 | - | - | - | 0.979 | - | - | Mlig455_013326 {REF} {Length: 1449} {Pfam: Fibronectin type II domain [PF00040.21, score=92.5]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=87.8, Expect=3e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=82.4, Expect=1e-16]; ENSMUSG00000031740, Mmp2, matrix metallopeptidase 2, [RH, Score=78.6, Expect=2e-15]} {Smed: dd_Smed_v6_14558_0_1, dd_Smed_v6_14558_0_1, [RH, Score=138, Expect=3e-38]} {RNA1310_38631} {RNA815_51136} Mlig455_013334 {REF} {Length: 1398} {Pfam: Fibronectin type II domain [PF00040.21, score=92.1]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=89.4, Expect=1e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=84.0, Expect=4e-17]} {Smed: dd_Smed_v6_12601_0_1, dd_Smed_v6_12601_0_1, [RH, Score=140, Expect=2e-38]} {RNA1310_38631} {RNA815_51136} |
76. | MligTC455_14102 | 31 | 0.65 | Mlig455_006004 | Neo: - Age: - |
0.978 | - | - | - | 0.978 | - | - | Mlig455_006004 {REF} {Length: 1106} {RNA1310_32319} {RNA815_18072} | |
77. | MligTC455_44354 | 1240 | 25.82 | Mlig455_001577 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.349 Region-specific R2: 5.143 Region-enriched R2: 4.498/0.00000 Regeneration-downregulated R2: -2.807 Regeneration-depleted R2: -2.807 |
0.978 | - | - | - | 0.978 | - | - | Mlig455_001577 {REF} {Length: 1028} {RNA1509_23470, RNA1509_33941, RNA1509_57202} {RNA1310_49541.2, RNA1509_23470, RNA1509_33941, RNA1509_57202} {RNA1509_23470, RNA1509_33941, RNA1509_57202, RNA815_59782} | |
78. | MligTC455_46451 | 229 | 4.76 | Mlig455_017183 | Neo: - Age: Down-Up-Down Region-specific R2: 5.510 Region-enriched R2: 5.394/0.00018 Regeneration-downregulated R2: -2.986 Regeneration-depleted R2: -2.986 |
0.978 | - | - | - | 0.978 | - | - | Mlig455_017183 {REF} {Length: 657} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.6]} {RNA1310_62963} {RNA815_31352} | |
79. | MligTC455_46452 | 134 | 2.79 | Mlig455_048151 | Neo: - Age: - Region-specific R2: 6.389 Region-enriched R2: 7.075/0.00014 Regeneration-downregulated R2: -3.162 Regeneration-depleted R2: -3.162 |
0.978 | - | - | - | 0.978 | - | - | Mlig455_048151 {REF} {Length: 618} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=25.7]} {RNA1310_62963} {RNA815_31352} | |
80. | MligTC455_51288 | 32 | 0.66 | Mlig455_033307 | Neo: - Age: - |
NRG2 | 0.978 | - | - | - | 0.978 | - | - | Mlig455_033307 {REF} {Length: 1876} {TRANSSPLICED} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=62.6]; Immunoglobulin domain [PF13927.8, score=57.8]; Immunoglobulin domain [PF00047.27, score=52.9]; Immunoglobulin domain [PF13895.8, score=42.7]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=21.9]; Immunoglobulin V-set domain [PF07686.19, score=21.5]} {Human: ENSG00000158458, NRG2, neuregulin 2, [RH, Score=78.6, Expect=9e-15]} {Mouse: ENSMUSG00000060275, Nrg2, neuregulin 2, [Score=79.3, Expect=5e-15]} {Dmel: FBgn0003984, vn, vein, [RH, Score=79.3, Expect=3e-15]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=58.5, Expect=1e-08]} {Smed: dd_Smed_v6_16809_0_1, dd_Smed_v6_16809_0_1, [RH, Score=77.8, Expect=3e-15]} {RNA1310_26045.2} {RNA815_30218} |
81. | MligTC455_05657 | 3 | 0.07 | Mlig455_045676 | Neo: - Age: - |
0.977 | - | - | - | 0.977 | - | - | Mlig455_045676 {REF} {Length: 2270} {Pfam: Polycystin cation channel [PF08016.14, score=31.8]} {RNA1310_39436.1} {RNA815_35444} | |
82. | MligTC455_19249 | 90 | 1.86 | Mlig455_054092 | Neo: - Age: Down-Up-Up Region-enriched R2: 7.298/0.00139 |
0.977 | - | - | - | 0.977 | - | - | Mlig455_054092 {REF} {Length: 667} {TRANSSPLICED} {RNA1509_57448} {RNA1310_51394, RNA1509_57448} {RNA1509_57448, RNA815_26076} | |
83. | MligTC455_25766 | 42 | 0.88 | Mlig455_008785, Mlig455_008821, Mlig455_008919 | Neo: - Age: - Region-enriched R2: 5.588/0.00166 |
0.977 | - | - | - | 0.977 | - | - | Mlig455_008785 {REF} {Length: 1744} {RNA1310_20437} {RNA815_15201} Mlig455_008821 {REF} {Length: 2074} {RNA1310_20437} {RNA815_15201} Mlig455_008919 {REF} {Length: 2074} {RNA1310_20437} {RNA815_15201} |
|
84. | MligTC455_26691 | 51 | 1.05 | Mlig455_044814 | Neo: - Age: - |
PDE9A | 0.977 | - | - | - | 0.977 | - | - | Mlig455_044814 {REF} {Length: 2691} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=286.2]} {Human: ENSG00000160191, PDE9A, phosphodiesterase 9A, [RH, Score=604, Expect=0.0]} {Mouse: ENSMUSG00000041119, Pde9a, phosphodiesterase 9A, [RH, Score=604, Expect=0.0]} {Dmel: FBgn0259171, Pde9, Phosphodiesterase 9, [RH, Score=354, Expect=1e-108]} {Celegans: WBGene00020114, pde-4, Probable 3',5'-cyclic phosphodiesterase pde-4, [Score=184, Expect=2e-51]} {Smed: dd_Smed_v6_13304_0_1, dd_Smed_v6_13304_0_1, [RH, Score=328, Expect=7e-106]} {RNA1310_14017} {RNA815_23817} |
85. | MligTC455_41967 | 159 | 3.32 | Mlig455_017184 | Neo: Int S/G2/M Age: Down-Up-Up Region-enriched R2: 7.330/0.00001 |
0.977 | - | - | - | 0.977 | - | - | Mlig455_017184 {REF} {Length: 1106} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=22.0]} {RNA1509_40628} {RNA1310_50753, RNA1509_40628} {RNA1509_40628, RNA815_21607} | |
86. | MligTC455_47851 | 36 | 0.76 | Mlig455_047832 | Neo: - Age: - |
PACRGL | 0.977 | - | - | - | 0.977 | - | - | Mlig455_047832 {REF} {Length: 1939} {Pfam: Parkin co-regulated protein [PF10274.11, score=119.9]} {Human: ENSG00000163138, PACRGL, parkin coregulated like, [RH, Score=167, Expect=1e-51]} {Mouse: ENSMUSG00000029089, 5730480H06Rik, RIKEN cDNA 5730480H06 gene, [RH, Score=152, Expect=1e-45]} {Dmel: FBgn0034454, CG15120, [Score=62.0, Expect=2e-11]} {RNA1310_58381} |
87. | MligTC455_49825 | 543 | 11.31 | Mlig455_069114 | Neo: - Age: Down-Up-Up Region-specific R2: 4.806 Region-enriched R2: 3.936/0.00000 |
0.977 | - | - | - | 0.977 | - | - | Mlig455_069114 {REF} {Length: 828} {Celegans: WBGene00003748, nlp-10, Neuropeptide-Like Protein, [Score=40.0, Expect=9e-06]} {RNA1509_26665} {RNA1310_48731, RNA1509_26665} {RNA1509_26665, RNA815_24488} | |
88. | MligTC455_11558 | 137 | 2.85 | Mlig455_058259 | Neo: - Age: logFC(26M/2M)=-0.792 |
0.976 | - | - | - | 0.976 | - | - | Mlig455_058259 {REF} {Length: 896} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=19.9]} {RNA1509_58923} {RNA1310_41706, RNA1509_58923} {RNA1509_58923, RNA815_20876} | |
89. | MligTC455_15182 | 24 | 0.49 | Mlig455_008075 | Neo: - Age: - |
0.976 | - | - | - | 0.976 | - | - | Mlig455_008075 {REF} {Length: 1623} {RNA1310_145272} | |
90. | MligTC455_17735 | 271 | 5.64 | Mlig455_017593, Mlig455_058810, Mlig455_058862 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.542 Region-enriched R2: 2.633/0.02130 |
0.976 | - | - | - | 0.976 | - | - | Mlig455_017593 {REF} {Length: 676} {TRANSSPLICED} {RNA1310_42115} {RNA815_33119} Mlig455_058810 {REF} {Length: 1574} {RNA1509_8571} {RNA1310_42115} {RNA815_33119} Mlig455_058862 {REF} {Length: 834} {TRANSSPLICED} {RNA1310_42115} {RNA815_33119} |
|
91. | MligTC455_19410 | 194 | 4.04 | Mlig455_047838 | Neo: - Age: Down-Up-Up Region-specific R2: 5.170 Region-enriched R2: 5.689/0.00000 |
0.976 | - | - | - | 0.976 | - | - | Mlig455_047838 {REF} {Length: 724} {TRANSSPLICED} {RNA1509_54915} {RNA1310_53549} {RNA815_27051} | |
92. | MligTC455_19411 | 68 | 1.41 | Mlig455_047909 | Neo: - Age: Down-Up-Down |
0.976 | - | - | - | 0.976 | - | - | Mlig455_047909 {REF} {Length: 748} {RNA1310_53549} {RNA815_27051} | |
93. | MligTC455_41195 | 25 | 0.53 | Mlig455_017236 | Neo: - Age: - |
0.976 | - | - | - | 0.976 | - | - | Mlig455_017236 {REF} {Length: 591} {NoTransDecoderORF} {RNA1310_58555} {RNA815_29982} | |
94. | MligTC455_47420 | 218 | 4.54 | Mlig455_017159, Mlig455_048110 | Neo: - Age: - Region-specific R2: 6.469 Region-enriched R2: 5.851/0.00135 |
0.976 | - | - | - | 0.976 | - | - | Mlig455_017159 {REF} {Length: 1062} {RNA1509_35349} {RNA1310_81586} Mlig455_048110 {REF} {Length: 527} {RNA1310_81586} |
|
95. | MligTC455_49824 | 466 | 9.71 | Mlig455_036536 | Neo: - Age: - Region-specific R2: 4.841 Region-enriched R2: 3.862/0.00010 |
0.976 | - | - | - | 0.976 | - | - | Mlig455_036536 {REF} {Length: 1139} {Pfam: Nucleoporin FG repeat region [PF13634.8, score=21.2]} {Celegans: WBGene00003748, nlp-10, Neuropeptide-Like Protein, [RH, Score=49.3, Expect=7e-08]} {RNA1509_18714, RNA1509_59524} {RNA1310_41906, RNA1509_18714, RNA1509_59524} {RNA1509_18714, RNA1509_59524, RNA815_24488} | |
96. | MligTC455_51653 | 188 | 3.92 | Mlig455_026873, Mlig455_030823, Mlig455_047794 | Neo: - Age: Down-Up-Down |
DNASE1L1 | 0.976 | - | - | - | 0.976 | - | - | Mlig455_026873 {REF} {Length: 2133} {Pfam: Endonuclease/Exonuclease/phosphatase family [PF03372.25, score=36.6]} {Human: ENSG00000013563, DNASE1L1, deoxyribonuclease 1 like 1, [RH, Score=167, Expect=5e-49]} {Mouse: ENSMUSG00000024136, Dnase1l2, deoxyribonuclease 1-like 2, [RH, Score=171, Expect=4e-51]} {RNA1310_32296.1} {RNA815_27566} Mlig455_030823 {REF} {Length: 2074} {Pfam: Endonuclease/Exonuclease/phosphatase family [PF03372.25, score=37.1]} {Human: ENSG00000013563, DNASE1L1, deoxyribonuclease 1 like 1, [RH, Score=167, Expect=2e-49]} {Mouse: ENSMUSG00000024136, Dnase1l2, deoxyribonuclease 1-like 2, [RH, Score=171, Expect=1e-51]} {RNA1310_32296.2} {RNA815_27566} Mlig455_047794 {REF} {Length: 1791} {Pfam: Endonuclease/Exonuclease/phosphatase family [PF03372.25, score=35.6]} {Human: ENSG00000013563, DNASE1L1, deoxyribonuclease 1 like 1, [RH, Score=166, Expect=2e-48]} {Mouse: ENSMUSG00000024136, Dnase1l2, deoxyribonuclease 1-like 2, [RH, Score=171, Expect=3e-51]} {RNA1310_32296.2} {RNA815_27566} |
97. | MligTC455_09510 | 314 | 6.55 | Mlig455_001134, Mlig455_042048 | Neo: - Age: - Region-specific R2: 5.291 Region-enriched R2: 5.151/0.00029 |
0.975 | - | - | - | 0.975 | - | - | Mlig455_001134 {REF} {Length: 485} {Pfam: Fingers domain of DNA polymerase lambda [PF10391.11, score=26.9]} {RNA1310_8738.1} {RNA815_21682.1} Mlig455_042048 {REF} {Length: 1550} {Pfam: Fingers domain of DNA polymerase lambda [PF10391.11, score=32.1]} {Dmel: FBgn0036416, CG7924, [RH, Score=61.2, Expect=1e-10]} {RNA1509_51261} {RNA1310_8738.1} {RNA815_21682.1} |
|
98. | MligTC455_10083 | 397 | 8.27 | Mlig455_000410, Mlig455_000477 | Neo: - Age: logFC(26M/2M)=1.533 Region-enriched R2: 3.033/0.00070 |
0.975 | - | - | - | 0.975 | - | - | Mlig455_000410 {REF} {Length: 1205} {RNA1509_50537} {RNA1310_48386} {RNA815_37422} Mlig455_000477 {REF} {Length: 1206} {RNA1509_50537} {RNA1310_48386} {RNA815_37422} |
|
99. | MligTC455_10226 | 119 | 2.48 | Mlig455_023508, Mlig455_023518, Mlig455_023617 | Neo: - Age: - |
0.975 | - | - | - | 0.975 | - | - | Mlig455_023508 {REF} {Length: 1311} {RNA1310_22533.2} {RNA815_23050} Mlig455_023518 {REF} {Length: 1413} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.5]} {RNA1310_22533.2} {RNA815_23050} Mlig455_023617 {REF} {Length: 1414} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.6]} {RNA1310_22533.2} {RNA815_23050} |
|
100. | MligTC455_10932 | 11 | 0.23 | Mlig455_022307, Mlig455_069887 | Neo: - Age: Down-Up-Up |
WSCD2 | 0.975 | - | - | - | 0.975 | - | - | Mlig455_022307 {REF} {Length: 844} {Pfam: WSC domain [PF01822.21, score=54.9]; PAN domain [PF00024.28, score=22.0]; MANEC domain [PF07502.16, score=19.4]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=59.7, Expect=6e-10]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=58.9, Expect=8e-10]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=58.5, Expect=8e-10]} {RNA1509_46267} {RNA1310_51656} {RNA815_29077.2} Mlig455_069887 {REF} {Length: 1280} {Pfam: WSC domain [PF01822.21, score=50.5]} {RNA1509_53783} {RNA1310_29335.2} {RNA815_9084.1} |